Baxter appoints Boston Scientific chief to board of directors

Baxter has announced the appointment of Michael Mahoney, president and chief executive officer of Boston Scientific, to its board of directors.

Mr Mahoney will serve on Baxter's corporate governance and compensation committees, a role that will leverage his extensive knowledge and experience of the medical technology sector.

He has served as the boss of Boston Scientific since 2012, having joined the company in the role of president in 2011. Prior to that, he served as worldwide chairman for the medical devices and diagnostic unit at Johnson and Johnson and as group chairman for DePuy.

Baxter believes Mr Mahoney will be able to offer a fresh perspective that will aid its internal governance and decision-making.

Robert Parkinson, Baxter's chairman and chief executive officer, said: "Mike's significant knowledge of the global medical products business and his track record of leadership will make a significant contribution to Baxter's board."

This comes after Munib Islam, a partner with the hedge fund Third Point, was appointed to Baxter's board of directors earlier this month.